Dihydroimidazothiazole derivatives

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 513/04 (2006.01) A61K 31/429 (2006.01)

Patent

CA 2597288

Compounds of formula (I) or pharmaceutically acceptable salts thereof, exhibit 5-HT1A agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition are useful for the treatment of obesity.

L'invention concerne des composés de la formule (I), ou des sels pharmaceutiquement acceptables de ceux-ci, qui présentent un agonisme 5-HT1A, outre l'inhibition de la recapture de la noradrénaline et éventuellement l'inhibition de la recapture de 5-HT, et qui sont utilisés dans le traitement de l'obésité.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dihydroimidazothiazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dihydroimidazothiazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydroimidazothiazole derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1812588

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.